拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 4498人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1511681, encodeId=ba15151168162, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？, objectType=article, longId=113380, objectId=f8ed113380c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ed113380c7, replyNumber=0, likeNumber=76, createdTime=2017-09-21, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ed113380c7, moduleTitle=β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ed113380c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511680, encodeId=d5a3151168017, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Eur Urol：向精密泌尿系肿瘤学方向迈进，一种新型的AR拮抗剂, objectType=article, longId=111153, objectId=af0d111153fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af0d111153fa, replyNumber=0, likeNumber=78, createdTime=2017-08-30, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af0d111153fa, moduleTitle=Eur Urol：向精密泌尿系肿瘤学方向迈进，一种新型的AR拮抗剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af0d111153fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511679, encodeId=b57f15116e980, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Am Heart J：盐皮质激素受体拮抗剂的高钾血症发生率究竟有多高？, objectType=article, longId=107606, objectId=b45010e60616, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b45010e60616, replyNumber=0, likeNumber=61, createdTime=2017-08-05, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b45010e60616, moduleTitle=Am Heart J：盐皮质激素受体拮抗剂的高钾血症发生率究竟有多高？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b45010e60616)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511678, encodeId=afe615116e878, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Hum Reprod Update：GnRH拮抗剂方案与激动剂长方案在IVF应用中的效果对比。, objectType=article, longId=107572, objectId=84ed10e572da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84ed10e572da, replyNumber=0, likeNumber=75, createdTime=2017-08-05, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84ed10e572da, moduleTitle=Hum Reprod Update：GnRH拮抗剂方案与激动剂长方案在IVF应用中的效果对比。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84ed10e572da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511677, encodeId=652715116e709, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACC：房颤合并肾功能不全患者非维生素K拮抗剂如何给药？, objectType=article, longId=106490, objectId=ff0810649016, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0810649016, replyNumber=0, likeNumber=76, createdTime=2017-07-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0810649016, moduleTitle=JACC：房颤合并肾功能不全患者非维生素K拮抗剂如何给药？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0810649016)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511676, encodeId=b7fe15116e6d6, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=维生素K拮抗剂联合阿司匹林增加房颤患者心梗风险吗？, objectType=article, longId=106237, objectId=cf0910623e3d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0910623e3d, replyNumber=0, likeNumber=57, createdTime=2017-07-23, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0910623e3d, moduleTitle=维生素K拮抗剂联合阿司匹林增加房颤患者心梗风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf0910623e3d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511675, encodeId=5f8a15116e53f, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=维生素K拮抗剂联合阿司匹林增加房颤患者心梗风险吗, objectType=article, longId=106236, objectId=fc2c10623665, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc2c10623665, replyNumber=0, likeNumber=54, createdTime=2017-07-23, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc2c10623665, moduleTitle=维生素K拮抗剂联合阿司匹林增加房颤患者心梗风险吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc2c10623665)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511674, encodeId=9d7015116e40b, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Circulation：服用非维生素K拮抗剂口服抗凝剂的急性缺血性中风患者使用rt-pa治疗的预后, objectType=article, longId=105502, objectId=6e1a105502b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e1a105502b5, replyNumber=0, likeNumber=70, createdTime=2017-07-16, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e1a105502b5, moduleTitle=Circulation：服用非维生素K拮抗剂口服抗凝剂的急性缺血性中风患者使用rt-pa治疗的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e1a105502b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511673, encodeId=5bfa15116e330, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACC:维生素K拮抗剂可降低房颤患者首次发生卒中和心肌梗死风险, objectType=article, longId=105336, objectId=497610533696, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=497610533696, replyNumber=0, likeNumber=60, createdTime=2017-07-14, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=497610533696, moduleTitle=JACC:维生素K拮抗剂可降低房颤患者首次发生卒中和心肌梗死风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=497610533696)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511672, encodeId=032415116e23d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Br J Pharmacol：桑色素——一种新的LXRα/β双重拮抗剂，能有效治疗非酒精性脂肪肝, objectType=article, longId=103235, objectId=443310323510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=443310323510, replyNumber=0, likeNumber=55, createdTime=2017-06-25, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=443310323510, moduleTitle=Br J Pharmacol：桑色素——一种新的LXRα/β双重拮抗剂，能有效治疗非酒精性脂肪肝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=443310323510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511671, encodeId=952b15116e147, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Am J Gastroenterol：非维生素K拮抗剂口服抗凝药胃肠道出血的风险真的很高吗？, objectType=article, longId=103070, objectId=481b1030e0eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=481b1030e0eb, replyNumber=0, likeNumber=45, createdTime=2017-06-24, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=481b1030e0eb, moduleTitle=Am J Gastroenterol：非维生素K拮抗剂口服抗凝药胃肠道出血的风险真的很高吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=481b1030e0eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511670, encodeId=cf5c15116e008, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=N Engl J Med：Elagolix，一种用于子宫内膜异位症相关疼痛治疗的口服促性腺激素释放激素拮抗剂, objectType=article, longId=99772, objectId=435599e72f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=435599e72f3, replyNumber=0, likeNumber=80, createdTime=2017-05-28, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=435599e72f3, moduleTitle=N Engl J Med：Elagolix，一种用于子宫内膜异位症相关疼痛治疗的口服促性腺激素释放激素拮抗剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=435599e72f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511669, encodeId=e2c2151166988, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=N Engl J Med：Elagolix，一种用于子宫内膜异位症相关疼痛治疗的口服促性腺激素释放激素拮抗剂。, objectType=article, longId=99717, objectId=0a0b99e171f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a0b99e171f, replyNumber=0, likeNumber=49, createdTime=2017-05-27, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a0b99e171f, moduleTitle=N Engl J Med：Elagolix，一种用于子宫内膜异位症相关疼痛治疗的口服促性腺激素释放激素拮抗剂。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a0b99e171f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511668, encodeId=509f1511668c8, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=SCI TRANSL MED：白三烯B4拮抗剂改善实验性淋巴水肿！, objectType=article, longId=98531, objectId=70849853148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70849853148, replyNumber=0, likeNumber=58, createdTime=2017-05-13, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70849853148, moduleTitle=SCI TRANSL MED：白三烯B4拮抗剂改善实验性淋巴水肿！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70849853148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511667, encodeId=fd72151166e45, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Clin Gastroenterol H：服用非维生素K拮抗剂口服抗凝剂患者的胃肠道出血风险如何？, objectType=article, longId=98224, objectId=914a9822419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=914a9822419, replyNumber=0, likeNumber=86, createdTime=2017-05-10, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=914a9822419, moduleTitle=Clin Gastroenterol H：服用非维生素K拮抗剂口服抗凝剂患者的胃肠道出血风险如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=914a9822419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511666, encodeId=5dc1151166648, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=ATVB：循环白细胞介素1受体拮抗剂和心血管疾病风险有何关系？, objectType=article, longId=96813, objectId=04ce9681342, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04ce9681342, replyNumber=0, likeNumber=71, createdTime=2017-04-24, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04ce9681342, moduleTitle=ATVB：循环白细胞介素1受体拮抗剂和心血管疾病风险有何关系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04ce9681342)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511665, encodeId=0c391511665bf, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布, objectType=article, longId=95067, objectId=4e789506ee8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e789506ee8, replyNumber=0, likeNumber=58, createdTime=2017-04-09, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e789506ee8, moduleTitle=《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e789506ee8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511664, encodeId=15ae1511664f8, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Lancet：神经激肽3受体拮抗剂可以作为一种新型更年期潮热治疗手段！, objectType=article, longId=94666, objectId=ca3b946661b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca3b946661b, replyNumber=0, likeNumber=21, createdTime=2017-04-06, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca3b946661b, moduleTitle=Lancet：神经激肽3受体拮抗剂可以作为一种新型更年期潮热治疗手段！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca3b946661b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511663, encodeId=7d7f1511663d3, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Lancet：单次吸入超细三联疗法与长效毒蕈碱受体拮抗剂治疗慢性阻塞性肺疾病哪个好？, objectType=article, longId=94661, objectId=450094661dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=450094661dd, replyNumber=0, likeNumber=66, createdTime=2017-04-06, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=450094661dd, moduleTitle=Lancet：单次吸入超细三联疗法与长效毒蕈碱受体拮抗剂治疗慢性阻塞性肺疾病哪个好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=450094661dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511662, encodeId=6658151166227, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=The Lancet：神经激肽3受体拮抗剂治疗更年期潮热, objectType=article, longId=94581, objectId=3b9694581e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b9694581e0, replyNumber=0, likeNumber=0, createdTime=2017-04-05, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b9694581e0, moduleTitle=The Lancet：神经激肽3受体拮抗剂治疗更年期潮热, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b9694581e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拮抗剂

2020-05-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？

2017-09-21

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Eur Urol：向精密泌尿系肿瘤学方向迈进，一种新型的AR拮抗剂

2017-08-30

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Am Heart J：盐皮质激素受体拮抗剂的高钾血症发生率究竟有多高？

2017-08-05

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Hum Reprod Update：GnRH拮抗剂方案与激动剂长方案在IVF应用中的效果对比。

2017-08-05

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JACC：房颤合并肾功能不全患者非维生素K拮抗剂如何给药？

2017-07-26

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

维生素K拮抗剂联合阿司匹林增加房颤患者心梗风险吗？

2017-07-23

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

维生素K拮抗剂联合阿司匹林增加房颤患者心梗风险吗

2017-07-23

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Circulation：服用非维生素K拮抗剂口服抗凝剂的急性缺血性中风患者使用rt-pa治疗的预后

2017-07-16

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JACC:维生素K拮抗剂可降低房颤患者首次发生卒中和心肌梗死风险

2017-07-14

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Br J Pharmacol：桑色素——一种新的LXRα/β双重拮抗剂，能有效治疗非酒精性脂肪肝

2017-06-25

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Am J Gastroenterol：非维生素K拮抗剂口服抗凝药胃肠道出血的风险真的很高吗？

2017-06-24

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

N Engl J Med：Elagolix，一种用于子宫内膜异位症相关疼痛治疗的口服促性腺激素释放激素拮抗剂

2017-05-28

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

N Engl J Med：Elagolix，一种用于子宫内膜异位症相关疼痛治疗的口服促性腺激素释放激素拮抗剂。

2017-05-27

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

SCI TRANSL MED：白三烯B4拮抗剂改善实验性淋巴水肿！

2017-05-13

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Clin Gastroenterol H：服用非维生素K拮抗剂口服抗凝剂患者的胃肠道出血风险如何？

2017-05-10

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

ATVB：循环白细胞介素1受体拮抗剂和心血管疾病风险有何关系？

2017-04-24

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布

2017-04-09

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Lancet：神经激肽3受体拮抗剂可以作为一种新型更年期潮热治疗手段！

2017-04-06

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Lancet：单次吸入超细三联疗法与长效毒蕈碱受体拮抗剂治疗慢性阻塞性肺疾病哪个好？

2017-04-06

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

The Lancet：神经激肽3受体拮抗剂治疗更年期潮热

2017-04-05

科室
- - 订阅+
  - 更多科室
工具
服务